|
Jul 30
|
United Therapeutics (UTHR) Misses Q2 Earnings Estimates
|
|
Jul 29
|
Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
|
May 26
|
Here's Why Karyopharm Therapeutics (KPTI) Is a Great 'Buy the Bottom' Stock Now
|
|
May 19
|
Does Karyopharm Therapeutics (KPTI) Have the Potential to Rally 521.62% as Wall Street Analysts Expect?
|
|
May 19
|
Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference
|
|
Feb 13
|
Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for
|
|
Feb 12
|
Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
|
|
Jan 2
|
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer
|
|
Jul 25
|
Karyopharm Therapeutics Inc. (KPTI): Is This One-Dollar Stock a Strong Buy Right Now?
|
|
Jul 15
|
Karyopharm Therapeutics Inc. (KPTI): Is This Penny Stock A Good Buy Right Now?
|
|
May 10
|
Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 9
|
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
|
May 9
|
Q1 2024 Karyopharm Therapeutics Inc Earnings Call
|
|
May 8
|
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
|
|
May 8
|
Karyopharm Therapeutics Reports Q1 2024 Financial Results: A Detailed Review
|
|
May 8
|
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
|
|
May 8
|
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
|
|
May 2
|
Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
|